pyridoxal has been researched along with Myocardial Ischemia in 1 studies
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunjan, S | 1 |
| Mason, RP | 1 |
| Mehta, VD | 1 |
| Kulkarni, PV | 1 |
| Aravind, S | 1 |
| Arora, V | 1 |
| Antich, PP | 1 |
1 other study available for pyridoxal and Myocardial Ischemia
| Article | Year |
|---|---|
Simultaneous intracellular and extracellular pH measurement in the heart by 19F NMR of 6-fluoropyridoxol.
Topics: Alkalosis, Respiratory; Animals; Extracellular Space; Fluorine Radioisotopes; Hydrogen-Ion Concentra | 1998 |